Biblio
Found 35 results
Author Keyword Title Type [ Year] Filters: Author is Schellenberg, Gerard D and First Letter Of Keyword is P [Clear All Filters]
“Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.
, “Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.
, “Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.
, “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.”, Nat Genet, vol. 43, no. 7, pp. 699-705, 2011.
, “Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.”, Nat Genet, vol. 43, no. 7, pp. 699-705, 2011.
, “Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.”, PLoS Genet, vol. 8, no. 6, p. e1002707, 2012.
, “DRAW+SneakPeek: analysis workflow and quality metric management for DNA-seq experiments.”, Bioinformatics, vol. 29, no. 19, pp. 2498-500, 2013.
, “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.
, “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.
, “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.
, “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.
, “Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.”, JAMA, vol. 309, no. 14, pp. 1483-92, 2013.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.”, PLoS Genet, vol. 10, no. 9, p. e1004606, 2014.
, “Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.”, PLoS Genet, vol. 10, no. 9, p. e1004606, 2014.
, “Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.”, JAMA Neurol, vol. 72, no. 11, pp. 1313-23, 2015.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “Rarity of the Alzheimer disease-protective APP A673T variant in the United States.”, JAMA Neurol, vol. 72, no. 2, pp. 209-16, 2015.
, “Rarity of the Alzheimer disease-protective APP A673T variant in the United States.”, JAMA Neurol, vol. 72, no. 2, pp. 209-16, 2015.
, “Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.”, Alzheimers Dement, vol. 12, no. 1, pp. 2-10, 2016.
, “A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.”, Nat Neurosci, vol. 20, no. 8, pp. 1052-1061, 2017.
,